Evidence map›Paper›PMID 40128304›Full record

ArticleScientific reports2025

Interspecies crosstalk between Magnaporthiopsis maydis and Fusarium verticillioides in mutually infected maize plants.

Galia Shofman, Ofir Degani

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. New azoxystrobin clay carrier to control corn late wilt disease.World journal of microbiology & biotechnology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Galia ShofmanPlant Sciences Department, MIGAL - Galilee Research Institute, Tarshish 2, 1101600, Kiryat Shmona, Israel.
Ofir DeganiPlant Sciences Department, MIGAL - Galilee Research Institute, Tarshish 2, 1101600, Kiryat Shmona, Israel. d-ofir@migal.org.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maize late wilt disease (LWD), caused by the fungus Magnaporthiopsis maydis, affects crops in Israel, Egypt, Spain, Portugal, India, and other countries. This study examines the interaction between M. maydis and Fusarium verticillioides, another post-flowering stalk rot pathogen. A confrontation assay revealed antagonism between the species. Fusarium verticillioides extrolites significantly hindered M. maydis in cross-cultivation. In a 40-day growth room test, introducing F. verticillioides at sowing and M. maydis one week later reduced plant growth to 44% of the control. Vice versa or simultaneous inoculation also stunted growth significantly (55% and 67%, respectively). Real-time PCR confirmed these growth responses by tracking both pathogens' DNA in plant roots. Similar trends were observed in a semi-field, full-season potted trial. Magnaporthiopsis maydis showed higher aggressiveness with a 40% plant survival rate compared to the minor influence of F. verticillioides. At harvest, M. maydis DNA levels were up to 1000-fold higher than F. verticillioides. Co-inoculation during seeding improved healthy plant rates from 10% (M. maydis alone) to 30%. Pre-infection with F. verticillioides followed by M. maydis resulted in 80% asymptomatic plants at harvest and significantly decreased M. maydis infection, though plant growth indices (particularly the yield) remained low. This study highlights the interactions between these pathogens, potentially limiting LWD damage.

Indexed as

AscomycotaFusariumPlant DiseasesZea maysHost-Pathogen InteractionsPlant RootsCephalosporium maydisCrop protectionDisease controlFungusHarpophora maydisLate wiltMicrobiomePathogenicityReal-time PCR

Identifiers

PMID40128304
PMCPMC11933429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.